166 related articles for article (PubMed ID: 29953500)
1. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells.
Silakit R; Kitirat Y; Thongchot S; Loilome W; Techasen A; Ungarreevittaya P; Khuntikeo N; Yongvanit P; Yang JH; Kim NH; Yook JI; Namwat N
PLoS One; 2018; 13(6):e0199827. PubMed ID: 29953500
[TBL] [Abstract][Full Text] [Related]
2. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.
Yang H; Li TW; Peng J; Tang X; Ko KS; Xia M; Aller MA
Gastroenterology; 2011 Jul; 141(1):378-88, 388.e1-4. PubMed ID: 21440549
[TBL] [Abstract][Full Text] [Related]
3. High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis.
Thongchot S; Yongvanit P; Loilome W; Seubwai W; Phunicom K; Tassaneeyakul W; Pairojkul C; Promkotra W; Techasen A; Namwat N
Asian Pac J Cancer Prev; 2014; 15(14):5873-8. PubMed ID: 25081716
[TBL] [Abstract][Full Text] [Related]
4. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1.
Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma.
Hu ZG; Zheng CW; Su HZ; Zeng YL; Lin CJ; Guo ZY; Zhong FD; Yuan GD; He SQ
J Cell Biochem; 2019 Jun; 120(6):9964-9978. PubMed ID: 30582202
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation.
Chen Y; Xu X; Wang Y; Zhang Y; Zhou T; Jiang W; Wang Z; Chang J; Liu S; Chen R; Shan J; Wang J; Wang Y; Li C; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):265. PubMed ID: 37821935
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
8. Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma.
Liu W; Chen H; Wong N; Haynes W; Baker CM; Wang X
Cancer Lett; 2017 May; 394():65-75. PubMed ID: 28257806
[TBL] [Abstract][Full Text] [Related]
9. The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma.
Wang Y; Zhang W; Chen L; Chen W; Xu S; Tang L; Yang Y; Li Q; Jiang Q; Miao L
Cell Oncol (Dordr); 2021 Aug; 44(4):907-916. PubMed ID: 34170484
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma.
Lin KY; Ye H; Han BW; Wang WT; Wei PP; He B; Li XJ; Chen YQ
Oncogene; 2016 Jun; 35(26):3376-86. PubMed ID: 26455324
[TBL] [Abstract][Full Text] [Related]
11. miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells.
Okamoto K; Miyoshi K; Murawaki Y
PLoS One; 2013; 8(10):e77623. PubMed ID: 24147037
[TBL] [Abstract][Full Text] [Related]
12. Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression.
Huang CK; Aihara A; Iwagami Y; Yu T; Carlson R; Koga H; Kim M; Zou J; Casulli S; Wands JR
Cancer Lett; 2016 Sep; 380(1):153-62. PubMed ID: 27364974
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.
Liu Z; Jin ZY; Liu CH; Xie F; Lin XS; Huang Q
Int J Clin Exp Pathol; 2015; 8(5):4684-94. PubMed ID: 26191158
[TBL] [Abstract][Full Text] [Related]
15. MiR-199a-3p enhances cisplatin sensitivity of cholangiocarcinoma cells by inhibiting mTOR signaling pathway and expression of MDR1.
Li Q; Xia X; Ji J; Ma J; Tao L; Mo L; Chen W
Oncotarget; 2017 May; 8(20):33621-33630. PubMed ID: 28422725
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma.
Mansini AP; Lorenzo Pisarello MJ; Thelen KM; Cruz-Reyes M; Peixoto E; Jin S; Howard BN; Trussoni CE; Gajdos GB; LaRusso NF; Perugorria MJ; Banales JM; Gradilone SA
Hepatology; 2018 Aug; 68(2):561-573. PubMed ID: 29406621
[TBL] [Abstract][Full Text] [Related]
17. HIF-1α/Ascl2/miR-200b regulatory feedback circuit modulated the epithelial-mesenchymal transition (EMT) in colorectal cancer cells.
Shang Y; Chen H; Ye J; Wei X; Liu S; Wang R
Exp Cell Res; 2017 Nov; 360(2):243-256. PubMed ID: 28899657
[TBL] [Abstract][Full Text] [Related]
18. Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc.
Wu YF; Li ZR; Cheng ZQ; Yin XM; Wu JS
Biomed Pharmacother; 2017 Dec; 96():7-13. PubMed ID: 28961507
[TBL] [Abstract][Full Text] [Related]
19. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
Zhang C; Tian W; Meng L; Qu L; Shou C
J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
He C; Wang L; Zhang J; Xu H
Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
